Three Synaptic Receptors Define Aggressiveness in Glioblastoma
Researchers identified a three-receptor signature involving HRH1, ADRA2B, and CHRM3 that defines glioblastoma aggressiveness and correlates with poor patient survival.
Researchers identified a three-receptor signature involving HRH1, ADRA2B, and CHRM3 that defines glioblastoma aggressiveness and correlates with poor patient survival.
A new review in Medical Oncology examines how organoid and assembloid technologies could overcome the limits of conventional models in ...
Penn Medicine researchers and clinicians will present clinical-trial research, professional priorities and communication strategies at ASTRO’s 68th Annual Meeting in ...
Single-cell sequencing and mouse experiments show that PTN-positive glioblastoma cells recruit anti-inflammatory macrophages through a PTN-NCL interaction, creating the immune ...
A new Oncotarget case report details how the WIN Consortium's international molecular tumor board evaluated investigational EGFR, MDM2, CDK4/6 and ...
An AI-driven single-cell and spatial multi-omics study defines three glioma ecosystem states and shows that a hypoxic myeloid-mesenchymal state independently ...
Sequencing of tumor tissue from 107 glioma patients reveals microbial signatures linked to tumor grade and survival, with predicted metabolic ...
A single-center retrospective cohort of 166 adults with newly diagnosed high-grade glioma found that scheduled resection patients spent 8.9 more ...
A retrospective MD Anderson cohort of nine adults with NF1-associated high-grade glioma found partial radiographic responses in two patients treated ...
An Ontario cohort study linked greater neighborhood material deprivation with 36.2 fewer adjusted days at home during the first year ...
A review frames microbiome-derived metabolites and mitochondrial activity as a proposed research axis for glioblastoma metabolism and immunity, while noting ...
A 2026 review links lactate-driven protein lactylation to glioblastoma growth, stemness, immune escape and treatment resistance in preclinical models, while ...
A 2026 collection of five reviews and one small tissue-expression study shows that autophagy can restrain or support solid tumors ...
A plant-derived sterol called stigmasterol sabotages the metabolic machinery of glioblastoma cells by impairing mitochondrial function and increasing oxidative stress, ...
Glioblastoma remains one of the most formidable opponents in modern oncology. This aggressive brain tumor, classified by the World Health ...
New research from Montreal reveals that the sorting receptor SORT1 links lipid remodeling, stemness and drug resistance in 3D glioblastoma ...
A new Oncoscience perspective maps the 2025–2026 glioblastoma clinical trial pipeline across four mechanistic domains, showing how biomarker-guided selection and ...
A rigorous 15-year single-center review of 385 ovarian mature teratomas reveals that somatic neoplasms arise in 3.1 percent of cases, ...
A retrospective study found that a dedicated best supportive care clinic achieved high appointment uptake and generated 29 CNS-led interventions ...
A biomimetic nanoplatform cloaked in microglial cell membranes delivers carbon monoxide, manganese ions, and Gasdermin E across the blood-brain barrier ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.